Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2747-2757

  Poisson, Caroline ^a   Rollin, Simon ^a   Véronneau, Steeve ^a   Bousquet, Simon M ^b   Larrivée, Jean François ^a   Le Gouill, Christian ^a   Boulay, Guylain ^b   Stankova, Jana ^a   Rola Pleszczynski, Marek ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; G ALPHA Q PROTEIN; INOSITOL PHOSPHATE; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; CAV1 PROTEIN, HUMAN; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; PEPTIDE FRAGMENT; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; EMBRYO; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LIPID RAFT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BINDING SITE; CALCIUM SIGNALING; CELL LINE; CHO CELL; CRICETULUS; ENZYMOLOGY; HAMSTER; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BINDING SITES; CALCIUM SIGNALING; CAVEOLAE; CAVEOLIN 1; CELL LINE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MEMBRANE MICRODOMAINS; PEPTIDE FRAGMENTS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 70149109003     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802651     Document Type: Article

References (68)

1. Benveniste, J., P. M. Henson, and C. G. Cochrane. 1972. Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils, and a plateletactivating factor. J. Exp. Med. 136: 1356-1377.
2. Honda, Z., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama, H. Okado, H. Toh, K. Ito, T. Miyamoto, et al. 1991. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349: 342-346. (Pubitemid 21912080)
3. Ishii, S., T. Nagase, and T. Shimizu. 2002. Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat. 68-. 69: 599-609.
4. Honda, Z., S. Ishii, and T. Shimizu. 2002. Platelet-activating factor receptor. J. Biochem. 131: 773-779.
5. Parent, J. L., C. L. Gouill, E. Escher, M. Rola-Pleszczynski, and J. Stakova. 1996. Identification of transmembrane domain residues determinant in the structurefunction relationship of the human platelet-activating factor receptor by sitedirected mutagenesis. J. Biol. Chem. 271: 23298-23303.
6. Lukashova, V., C. Asselin, J. J. Krolewski, M. Rola-Pleszczynski, and J. Stankova. 2001. G-protein-independent activation of Tyk2 by the plateletactivating factor receptor. J. Biol. Chem. 276: 24113-24121.
7. Chen, Z., D. J. Dupre, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova. 2002. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation: role of the C terminus and the (D/N)PXXY motif. J. Biol. Chem. 277: 7356-7362.
8. Dupre, D. J., Z. Chen, C. Le Gouill, C. Theriault, J. L. Parent, M. Rola-Pleszczynski, and J. Stankova. 2003. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor. J. Biol. Chem. 278: 48228-48235.
9. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
10. Engelman, J. A., C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamoto, D. S. Kohtz, and M. P. Lisanti. 1998. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo: a role for the caveolin-scaffolding domain. FEBS Lett. 428: 205-211.
11. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273: 5419-5422.
12. Smart, E. J., G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19: 7289-7304.
13. Galbiati, F., B. Razani, and M. P. Lisanti. 2001. Emerging themes in lipid rafts and caveolae. Cell 106: 403-411.
14. Song, K. S., S. Li, T. Okamoto, L. A. Quilliam, M. Sargiacomo, and M. P. Lisanti. 1996. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains: detergent-free purification of caveolae microdomains. J. Biol. Chem. 271: 9690-9697.
15. Oka, N., M. Yamamoto, C. Schwencke, J. Kawabe, T. Ebina, S. Ohno, J. Couet, M. P. Lisanti, and Y. Ishikawa. 1997. Caveolin interaction with protein kinase C: isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J. Biol. Chem. 272: 33416-33421.
16. Oh, P., and J. E. Schnitzer. 2001. Segregation of heterotrimeric G proteins in cell surface microdomains: Gq binds caveolin to concentrate in caveolae, whereas Gi and Gs target lipid rafts by default. Mol. Biol. Cell 12: 685-698. (Pubitemid 33052021)
17. Couet, J., S. Li, T. Okamoto, T. Ikezu, and M. P. Lisanti. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272: 6525-6533.
18. Thivierge, M., J. L. Parent, J. Stankova, and M. Rola-Pleszczynski. 1996. Modulation of human platelet-activating factor receptor gene expression by protein kinase C activation. J. Immunol. 157: 4681-4687.
19. Mandal, S. K., A. Iakhiaev, U. R. Pendurthi, and L. V. Rao. 2005. Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. Blood 105: 153-160.
20. Cayouette, S., M. P. Lussier, E. L. Mathieu, S. M. Bousquet, and G. Boulay. 2004. Exocytotic insertion of TRPC6 channel into the plasma membrane upon Gq protein-coupled receptor activation. J. Biol. Chem. 279: 7241-7246.
21. 2+ entry. Cell 85: 661-671.
22. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
23. Le Gouill, C., J. L. Parent, M. Rola-Pleszczynski, and J. Stankova. 1997. Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor. J. Biol. Chem. 272: 21289-21295.
24. Smart, E. J., Y. S. Ying, C. Mineo, and R. G. Anderson. 1995. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. USA 92: 10104-10108.
25. Sprenger, R. R., D. Speijer, J. W. Back, C. G. De Koster, H. Pannekoek, and A. J. Horrevoets. 2004. Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 25: 156-172.
26. Perron, A., Z. G. Chen, D. Gingras, D. J. Dupre, J. Stankova, and M. Rola-Pleszczynski. 2003. Agonist-independent desensitization and internalization of the human platelet-activating factor receptor by coumermycin-gyrase B-induced dimerization. J. Biol. Chem. 278: 27956-27965.
27. Sargiacomo, M., P. E. Scherer, Z. Tang, E. Kubler, K. S. Song, M. C. Sanders, and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA 92: 9407-9411.
28. Monier, S., R. G. Parton, F. Vogel, J. Behlke, A. Henske, and T. V. Kurzchalia. 1995. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 6: 911-927.
29. Lisanti, M. P., Z. L. Tang, and M. Sargiacomo. 1993. Caveolin forms a heterooligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J. Cell Biol. 123: 595-604.
30. Schlegel, A., and M. P. Lisanti. 2000. A molecular dissection of caveolin-1 membrane attachment and oligomerization: two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J. Biol. Chem. 275: 21605-21617.
31. Ukena, D., G. Dent, F. W. Birke, C. Robaut, G. W. Sybrecht, and P. J. Barnes. 1988. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. FEBS Lett. 228: 285-289.
32. 3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung. Eur. J. Pharmacol. 169: 313-316.
33. Petrie, R. J., P. P. Schnetkamp, K. D. Patel, M. Awasthi-Kalia, and J. P. Deans. 2000. Transient translocation of the B cell receptor and Src homology 2 domaincontaining inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J. Immunol. 165: 1220-1227.
34. Solomon, S., M. Masilamani, L. Rajendran, M. Bastmeyer, C. A. Stuermer, and H. Illges. 2002. The lipid raft microdomain-associated protein reggie-1/flotillin-2 is expressed in human B cells and localized at the plasma membrane and centrosome in PBMCs. Immunobiology 205: 108-119. (Pubitemid 34285410)
35. Rajendran, L., M. Masilamani, S. Solomon, R. Tikkanen, C. A. Stuermer, H. Plattner, and H. Illges. 2003. Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc. Natl. Acad. Sci. USA 100: 8241-8246.
36. Slaughter, N., I. Laux, X. Tu, J. Whitelegge, X. Zhu, R. Effros, P. Bickel, and A. Nel. 2003. The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation. Clin. Immunol. 108: 138-151.
37. Anderson, R. G. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225.
38. Pike, L. J. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 44: 655-667.
39. Pfleger, K. D., and K. A. Eidne. 2003. New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors. Pituitary 6: 141-151.
40. Heding, A. 2004. Use of the BRET 7TM receptor/β-arrestin assay in drug discovery and screening. Expert Rev. Mol. Diagn. 4: 403-411.
41. Angers, S., A. Salahpour, E. Joly, S. Hilairet, D. Chelsky, M. Dennis, and M. Bouvier. 2000. Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. USA 97: 3684-3689.
42. Hanyaloglu, A. C., R. M. Seeber, T. A. Kohout, R. J. Lefkowitz, and K. A. Eidne. 2002. Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes: differential regulation of β-arrestins 1 and 2. J. Biol. Chem. 277: 50422-50430.
43. Pfeiffer, M., S. Kirscht, R. Stumm, T. Koch, D. Wu, M. Laugsch, H. Schroder, V. Hollt, and S. Schulz. 2003. Heterodimerization of substance P and μ-opioid receptors regulates receptor trafficking and resensitization. J. Biol. Chem. 278: 51630-51637.
44. Leclerc, P. C., M. Auger-Messier, P. M. Lanctot, E. Escher, R. Leduc, and G. Guillemette. 2002. A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology 143: 4702-4710.
45. Resh, M. D. 2004. Membrane targeting of lipid modified signal transduction proteins. Subcell. Biochem. 37: 217-232.
46. Neumann-Giesen, C., B. Falkenbach, P. Beicht, S. Claasen, G. Luers, C. A. Stuermer, V. Herzog, and R. Tikkanen. 2004. Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression. Biochem. J. 378: 509-518.
47. Morrow, I. C., S. Rea, S. Martin, I. A. Prior, R. Prohaska, J. F. Hancock, D. E. James, and R. G. Parton. 2002. Flotillin-1/Reggie-2 traffics to surface raft domains via a novel Golgi-independent pathway: identification of a novel membrane targeting domain and a role for palmitoylation. J. Biol. Chem. 277: 48834-48841.
48. Moffett, S., D. A. Brown, and M. E. Linder. 2000. Lipid-dependent targeting of G proteins into rafts. J. Biol. Chem. 275: 2191-2198.
49. Izumi, T., and T. Shimizu. 1995. Platelet-activating factor receptor: gene expression and signal transduction. Biochim. Biophys. Acta 1259: 317-333.
50. Marrache, A. M., F. Gobeil, Jr., S. G. Bernier, J. Stankova, M. Rola-Pleszczynski, S. Choufani, G. Bkaily, A. Bourdeau, M. G. Sirois, A. Vazquez-Tello, et al. 2002. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol. 169: 6474-6481.
51. Krajewska, W. M., and I. Maslowska. 2004. Caveolins: structure and function in signal transduction. Cell. Mol. Biol. Lett. 9: 195-220. (Pubitemid 38902217)
52. Li, S., T. Okamoto, M. Chun, M. Sargiacomo, J. E. Casanova, S. H. Hansen, I. Nishimoto, and M. P. Lisanti. 1995. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270: 15693-15701.
53. Svoboda, P., J. Teisinger, J. Novotny, L. Bourova, T. Drmota, L. Hejnova, Z. Moravcova, V. Lisy, V. Rudajev, J. Stohr, et al. 2004. Biochemistry of transmembrane signaling mediated by trimeric G proteins. Physiol. Res. 53(Suppl. 1): S141-S152.
54. Matousek, P., D. Durchankova, I. Svandova, J. Novotny, and P. Svoboda. 2005. Agonist-induced tyrosine phosphorylation of Gq/G11 α requires the intact structure of membrane domains. Biochem. Biophys. Res. Commun. 328: 526-532.
55. Bhatnagar, A., D. J. Sheffler, W. K. Kroeze, B. Compton-Toth, and B. L. Roth. 2004. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gαq-coupled protein receptors. J. Biol. Chem. 279: 34614-34623.
56. Carlson, S. A., T. K. Chatterjee, and R. A. Fisher. 1996. The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins: studies using intracellular domain minigenes and receptor chimeras. J. Biol. Chem. 271: 23146-23153.
57. Dupre, D. J., C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova. 2001. Inverse agonist activity of selected ligands of platelet-activating factor receptor. J. Pharmacol. Exp. Ther. 299: 358-365. (Pubitemid 32905154)
58. Amatruda, T. T., III, N. P. Gerard, C. Gerard, and M. I. Simon. 1993. Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268: 10139-10144.
59. Chen, L. W., M. W. Lin, and C. M. Hsu. 2005. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. J. Biomed. Sci. 12: 311-319.
60. Wang, H., and S. Chakrabarty. 2003. Platelet-activating factor activates mitogenactivated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells. Oncogene 22: 2186-2191.
61. Cuschieri, J., D. Gourlay, E. Bulger, I. Garcia, S. Jelacic, and R. V. Maier. 2002. Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. Surgery 132: 157-166.
62. Marques, S. A., L. C. Dy, M. D. Southall, Q. Yi, E. Smietana, R. Kapur, M. Marques, J. B. Travers, and D. F. Spandau. 2002. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J. Pharmacol. Exp. Ther. 300: 1026-1035.
63. Maruoka, S., S. Hashimoto, Y. Gon, I. Takeshita, and T. Horie. 2000. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. Am. J. Respir. Crit. Care Med. 161: 922-929.
64. Miike, S., K. Kurasawa, Y. Saito, and I. Iwamoto. 2000. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. J. Leukocyte Biol. 67: 117-126. (Pubitemid 30046826)
65. Bazan, H. E., and L. Varner. 1997. A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet activating factor (PAF) in corneal epithelium. Curr. Eye Res. 16: 372-379.
66. Franklin, R. A., A. Tordai, B. Mazer, N. Terada, J. Lucas, and E. W. Gelfand. 1995. Platelet activating factor activates MAPK and increases in intracellular calcium via independent pathways in B lymphocytes. Biochem. Biophys. Res. Commun. 209: 1111-1118.
67. Honda, Z., T. Takano, Y. Gotoh, E. Nishida, K. Ito, and T. Shimizu. 1994. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J. Biol. Chem. 269: 2307-2315. (Pubitemid 24035448)
68. Chen, Z., M. Rola-Pleszczynski, and J. Stankova. 2003. Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalization and G-protein activation. Cell. Signal. 15: 843-850. (Pubitemid 36776658)